<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJSTA</journal-id><journal-title-group><journal-title>Open Journal of Synthesis Theory and Applications</journal-title></journal-title-group><issn pub-type="epub">2168-1244</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojsta.2013.22006</article-id><article-id pub-id-type="publisher-id">OJSTA-29631</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Nuclear-Chemical Synthesis of 1,4-Diazine Quaternary Salts
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>adezhda</surname><given-names>E. Shchepina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Viktor</surname><given-names>V. Avrorin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gennadii</surname><given-names>A. Badun</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Laboratory of Radiochemistry, Natural Sciences Institute of Perm State University, Perm, Russia</addr-line></aff><aff id="aff3"><addr-line>Radiochemistry Department, M. V. Lomonosov Moscow State University, Moscow, Russia</addr-line></aff><aff id="aff2"><addr-line>Chemistry Department, St-Petersburg State University, St-Petersburg, Russia</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>neshchepina@mail.ru(AES)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>04</month><year>2013</year></pub-date><volume>02</volume><issue>02</issue><fpage>51</fpage><lpage>55</lpage><history><date date-type="received"><day>December</day>	<month>3,</month>	<year>2012</year></date><date date-type="rev-recd"><day>February</day>	<month>2,</month>	<year>2013</year>	</date><date date-type="accepted"><day>February</day>	<month>21,</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   Ion-molecular reactions of nucleogenic phenyl cations with the nucleophilic centers of 1,4-diazines have been investigated for the first time. Previously unknown tritium labeled N-phenyl quaternary derivatives of pyrazine and quinoxaline, which are potential radioactive biomarkers, have been obtained by nuclear-chemical method. 
 
</p></abstract><kwd-group><kwd>Nucleogenic Phenyl Cations; 1</kwd><kwd>4-Diazines; Quaternization; Tritium Labeling</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Diazines attribute to the six-ring heterocycles with two heteroatoms both of which are nitrogen atoms. Cyclic pyrazine system forms common structural fragment of 1, 4-diazines. Benzopyrazine or quinoxaline has pyrazine cycle annulated with the benzene ring. 1,4-Diazines and condensed systems with pyrazine ring are known as an important type of heterocyclic derivatives with high biologic activity [1-4]. Synthetic pyrazines exhibit a wide range of physiological activities including antibacterial, antimycobacterial, antiprotozoal and antitumor [5-9]. These promissing results stimulate chemists and biologists for further research in the field of pyrazine derivatives over the last few years [10-22].</p><p>Modern progress in biology, biochemistry and molecular genetics along with the experimental medicine is largely determined by the wide application of labeled, especially tritium labeled compounds, for the sensitive direct studies of the biochemical reaction mechanisms and metabolic pathways of the essential pharmaceuticals [23-36].</p><p>Owing to this the development of easy and unusual methods for synthesis of new 1,4-diazine derivatives along with tritium labeling becomes an urgent task. Previously we have applied the elaborated nuclear-chemical method based on the consequences of tritium b-decay for the one-step preparation of unknown and hardly available derivatives of monoazines, effective tritium labeled biological markers [37-41].</p></sec><sec id="s2"><title>2. Experimental</title><sec id="s2_1"><title>2.1. Tritium Double Labeled Benzene</title><p>Benzene double labeled with tritium was obtained from 1, 4-dibromobenzene (3.4 mg, 0.014 mmol), and n-Bu<sub>3</sub>N (5.0 ml, 0.020 mmol) in hexane, and tritium gas (3.3 Ci, 0.054 mmol) by dehalogenation on a 5% Pd/BaSO<sub>4</sub> catalyst for 1 h at room temperature [<xref ref-type="bibr" rid="scirp.29631-ref39">39</xref>]. The chemical purity of the synthesized doubly labeled benzene was not less than 99%. Analysis of tritium-labeled benzene was carried out by gas chromatography. The volume specific activity of the obtained solution in hexane was 1 Ci/ml.</p></sec><sec id="s2_2"><title>2.2. Nuclear-Chemical Synthesis</title><p>Crystals of the stabilizing salt KBF<sub>4</sub> (~200 mg) were placed in 0.5 ml glass ampoules, then 0.055 mmol of substrates: pyrazine (4.4 mg,) or quinoxaline (7.2 mg) dissolved in ether were placed on the salt crystals. The ether was distilled off in vacuum, and after cooling the ampoules with liquid nitrogen, a C<sub>6</sub>H<sub>4</sub>T<sub>2</sub> hexane solution (1 ml) was added. The C<sub>6</sub>H<sub>4</sub>T<sub>2 </sub>concentration was selected so that the ratio of labeled benzene to substrate was not less than ~1:1000. The ampoules were sealed, and stored for 1 - 2 months at −15˚C for accumulation of the nuclear-chemical synthesis products. The ampoules were opened, the contents were transferred to special vials, and benzene (0.5 ml) was added, followed by the carrier acetone solution (0.5 ml), (1 mg/ml). Due to the absence of isotopic carriers the unlabeled N-phenylpyridinium and quinolinium salts [37,42] were used. Unreacted C<sub>6</sub>H<sub>4</sub>T<sub>2</sub> was removed by distillation in vacuum. Acetone (0.5 ml) was added to the dry residue and samples (about 5 ml) were taken for isolation of labeled compounds by TLC.</p></sec><sec id="s2_3"><title>2.3. TLC Radiochromatography</title><p>Radiochromatography of the obtained tritiated compounds was carried out on glass plates with Analtech TLC Uniplates C18 Reverse Phase silica gel (Fluorescent Indicator) in MeCN. Bands of the chromatographic adsorption layer measuring 0.5 cm in length were removed into dioxane scintillator and their b-radioactivity measured with the aid of a Rack Beta (Finland) liquid scintillation counter. Typical radiochromatograms are shown on Figures 1 and 2.</p><p>First peaks on the radiochromatograms correspond to the quaternary salts. Relative yields of ion-molecular reactions products were determined as a ratio of the radioactivity of an individual compound towards the sum of all tritium labeled products.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><p>Generation of nucleogenic phenyl cations (cations formed by radioactive decay) occurs by spontaneous β-decay of tritium in the labeled benzene. Nuclear-chemical method provides unique opportunity for unusual formation of carbocations along with the several essential advantages: 1) obtained phenyl cations are free, that means without counterion; 2) investigated ion-molecular reactions take place on the surface of stabilizing salt without a solvent; 3) all reactions are carried out in the very mild conditions since decay processes are independent from temperature, pressure and so on.</p><p>The presence of at least two atoms of tritium in the benzene molecule leads to the preparation of cations labeled with tritium (Scheme 1).</p><p>The proposed scheme (Scheme 2) for the ion-molecular interactions of nucleogenic phenyl cations with quinoxaline (for example) may be represented in the following manner.</p><p>Upon the interactions of free phenyl cations with the investigated diazines, quaternary salts are formed by Ad<sub>E</sub> (electrophilic addition) as well as substitution products formed by S<sub>E</sub> (electrophilic substitution) are produced.</p><p>The radiochemical yields of the quaternary salts for the investigated 1,4-diazines are shown in <xref ref-type="table" rid="table1">Table 1</xref>. Pyrazines have considerable aromatic character; therefore their main reactivity pathways can be predicted by regarding them as pyridines which have a nitrogen atom in the para-position.</p><p>Nitrogen atom in azines possesses a pair of electrons, which is not involved in the formation of σ or π bonding orbitals. Those electrons may form a bond between the</p><p><img src="1-2520028\2a91a632-7957-4b0d-9b32-5c641f9616ac.jpg" /></p><p>Scheme 1. Generation of nucleogenic phenyl cations.</p><p><img src="1-2520028\d83dad97-620c-454a-8f0f-c301776e5d30.jpg" /></p><p>Scheme 2. Pathways of ion-molecular interactions of nucleogenic phenyl cations with quinoxaline.</p><p><xref ref-type="table" rid="table1">Table 1</xref>. Radiochemical yields of the quaternary salts.</p><p><img src="1-2520028\a4d2acbf-7da5-4ad4-b67b-43126dd22170.jpg" /></p><p>nitrogen atom and a carbon atom, which causes the nitrogen atom to become quaternary [<xref ref-type="bibr" rid="scirp.29631-ref43">43</xref>]. Unfortunately only alkyl quaternary derivatives are known for 1,4-diazines. Moreover, N-phenyl derivatives of 1,4-diazines haven’t been obtained by any methods of classical chemistry yet.</p><p>Pyrazine and quinoxaline are weakly basic (pK<sub>a</sub> ~ 0.6) [20,21,44], therefore the diquaternarization reaction of such derivatives for a long time wasn’t available in practice. It was suspected that these failures arise from the expected reduction in nucleophilicity of the second nitrogen attendant upon quaternization of the first. However, the use of more potent trialkyloxonium fluoroborates as alkylating agents led to the formation of several pyrazinium diquats [<xref ref-type="bibr" rid="scirp.29631-ref45">45</xref>]. The success was attributed to the presence of two positive charges in a conjugated ring, which enhanced its reactivity.</p><p>It is well-known that most N-phenyl quaternary salts of azines are not prepared by direct quaternization but rather the nitrogen substituent is introducing before the ring closure [<xref ref-type="bibr" rid="scirp.29631-ref43">43</xref>]. We have extended our elaborated nuclear-chemical method for the direct phenylation of nitrogen atom in 1,4-diazines. In spite of relatively small radiochemical yields of N-phenyl quaternary derivatives of pyrizane and quinoxaline (<xref ref-type="table" rid="table1">Table 1</xref>) it may be considered as a first step in the new field of previously unknown N-aryl quaternary diazine compounds. Use of free nucleogenic phenyl cations may also lead to the formation of diquaternary derivatives (the second peaks on the radiochromatograms). In the case of quinoxaline (<xref ref-type="fig" rid="fig2">Figure 2</xref>), several peaks can be attributed to the products of electrophilic substitution into the benzene ring. This theory is further collaborated by the comparison between quinoxaline and pyrazine diagrams (Figures 1 and 2 correspondently).</p><p>Further research will be undertaken for the detail investigations of ion-molecular interactions of nucleogenic phenyl cations with the nucleophilic centers of 1,4-diazines.</p></sec><sec id="s4"><title>4. Conclusion</title><p>Elaborated nuclear-chemical method of synthesis enables a new way of the direct nitrogen atom phenylation by the nucleogenic phenyl cations in 1,4-diazines, furnishing previously unknown N-phenyl quaternary derivatives.</p></sec><sec id="s5"><title>5. Acknowledgements</title><p>The authors gratefully acknowledge the financial support of the Russian Foundation for Basic Research (Project No. 10-03-00685a).</p></sec><sec id="s6"><title>REFERENCES</title></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.29631-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">G. W. H. Cheeseman and E. S. G. Werstiuk, “Recent Advances in Pyrazine Chemistry,” Advances in Heterocyclic Chemistry, Vol. 14, 1972, pp. 99-209.  
doi:10.1016/S0065-2725(08)60953-8</mixed-citation></ref><ref id="scirp.29631-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">A. Dell, D. H. Williams, H. R. Morris, G. A. Smith, J. Feeney and G. C. K. Roberts, “Structure Revision of the Antibiotic Echinomycin,” Journal of the American Chemical Society Vol. 97, No. 9, 1975, pp. 2497-2502.  
doi:10.1021/ja00842a029</mixed-citation></ref><ref id="scirp.29631-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">W. Kaim, “The Versatile Chemistry of 1,4-Diazines: Organic, Inorganic and Biochemical Aspects,” Angewandte Chemie International Edition, Vol. 22, No. 3, 1983, pp. 171-258. doi:10.1002/anie.198301713</mixed-citation></ref><ref id="scirp.29631-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">A. F. Pozharskii, A. T. Soldatenkov and A. R. Katritzky, “Heterocycles in Life and Society,” 1st Edition, John Wiley &amp; Sons Ltd., Chichester, 1997.</mixed-citation></ref><ref id="scirp.29631-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">J. Renault, M. Baron, P. Mailliet, S,Giorgirenault, C. Paoletti and S. Cros, “Heterocyclic Quinones. 2. Quinoxaline-5,6-(and 5-8)-Diones-Potential Antitumoral Agents,” European Journal of Medicinal Chemistry, Vol. 16, No. 6, 1981, pp. 545-550.</mixed-citation></ref><ref id="scirp.29631-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">L. E. Seitz, W. J. Suling and R. C. Reynolds, “Synthesis and Antimycobacterial Activity of Pyrazine and Quinoxaline Derivatives,” Journal of Medicinal Chemistry, Vol. 45, No. 25, 2002, pp. 5604-5606. doi:10.1021/jm020310n</mixed-citation></ref><ref id="scirp.29631-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">A. Jaso, B. Zarranz, I. Aldana and A. Monge, “Synthesis of New Quinoxaline-2-Carboxylate 1,4-Dioxide Derivatives as Anti-Mycobacterium Tuberculosis Agents,” Journal of Medicinal Chemistry, Vol. 48, No. 6, 2005, pp. 2019-2025. doi:10.1021/jm049952w</mixed-citation></ref><ref id="scirp.29631-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">X. Hui, J. Desrivot, C. Bories, P. M. Loiseau, X. Franck, R. Hocquemiller and B. Figadère, “Synthesis and Antiprotozoal Activity of Some New Synthetic Substituted Quinoxalines,” Bioorganic &amp; Medicinal Chemistry Letters, Vol. 16, No. 4, 2006, pp. 815-820.  
doi:10.1016/j.bmcl.2005.11.025</mixed-citation></ref><ref id="scirp.29631-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">H. Gao, E. F. Yamasaki, K. K. Chan, L. L. Shen and R. M. Snapka, “DNA Sequence Specificity for Topoisomerase II Poisoning by the Quinoxaline Anticancer Drugs XK469 and CQS,” Molecular Pharmacology, Vol. 63, No. 6, 2003, pp. 1382-1388. doi:10.1124/mol.63.6.1382</mixed-citation></ref><ref id="scirp.29631-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">P. P. Castro, G. Zhao, G. A. Masangkay, C. Hernandez and L. M. Gutierrez-Tunstad, “Quinoxaline Excision: A Novel Approach to Triand Diquinoxaline Cavitands,” Organic Letters, Vol. 6, No. 10, 2004, pp. 333-336.  
doi:10.1021/ol036045x</mixed-citation></ref><ref id="scirp.29631-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">H. Gali-Muhtasib, M. Sidani, F. Geara, A.-D. Mona, J. Al-Hmaira, M. J. Haddadin and G. Zaatari, “Quinoxaline 1,4-Dioxides Are Novel Angiogenesis Inhibitors That Potentiate Antitumor Effects of Ionizing Radiation,” International Journal of Oncology, Vol. 24, No. 5, 2004, pp. 1121-1131.</mixed-citation></ref><ref id="scirp.29631-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">K. R. J. Thomas, M. Velusamy, J. T. Lin, C.-H. Chuen and Y.-T. Tao, “Chromophore-Labeled Quinoxaline Derivatives as Efficient Electroluminescent Materials,” Chemistry of Materials, Vol. 17, No. 7, 2005, pp. 1860-1866.  
doi:10.1021/cm047705a</mixed-citation></ref><ref id="scirp.29631-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">J. Ishida, H. Yamamoto, Y. Kido, K. Kamijo, K. Murano, H. Miyake, M. Ohkubo, T. Kinoshita, M. Warizaya, A. Iwashita, K. Mihara, N. Matsuoka and K. Hattori, “Discovery of Potent and Selective PARP-1 and PARP-2 Inhibitors: SBDD Analysis via a Combination of X-Ray Structural Study and Homology Modeling,” Bioorganic &amp; Medicinal Chemistry, Vol. 14, No. 5, 2006, pp. 1378-1390. doi:10.1016/j.bmc.2005.09.061</mixed-citation></ref><ref id="scirp.29631-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">C. Urquiola, D. Gambino, M. Cabrera, M. L. Lavaggi, H. Cerecetto, M. Gonzalez, A. Lopez de Cerain, A. Monge, A. J. Costa-Filho and M. H. Torre, “New Copper-Based Complexes with Quinoxaline N1, N4-Dioxide Derivatives, Potential Antitumoral Agents,” Journal of Inorganic Biochemistry, Vol. 102, No. 1, 2008, pp. 119-126.  
doi:10.1016/j.jinorgbio.2007.07.028</mixed-citation></ref><ref id="scirp.29631-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">H. A. Shindy and H. A. Soleiman, “Synthesis and Spectral Behaviour of Some Quinoxaline Cyanine Dyes,” Canadian Journal on Chemical Engineering &amp; Technology, Vol. 1, No. 4, 2010, pp. 44-59.</mixed-citation></ref><ref id="scirp.29631-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">D. P. Singh, S. K. Deivedi, S. R. Hashim and R. G. Singhal, “Synthesis and Antimicrobial Activity of Some New Quinoxaline Derivatives,” Pharmaceuticals, Vol. 3, No. 8, 2010, pp. 2416-2425.  
doi:10.3390/ph3082416</mixed-citation></ref><ref id="scirp.29631-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">R. M. Rajurkar, V. A. Agrawal, S. S. Thonte and R. G. Ingale, “Heterocyclic Chemistry of Quinoxaline and Potential Activities of Quinoxaline Derivatives. A Review,” Pharmacophore, Vol. 1, No. 2, 2010, pp. 65-76.</mixed-citation></ref><ref id="scirp.29631-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">K. Kudo, A. Momotake, Y. Kanna, Y. Nishimura and T. Arai, “Development of a Quinoxaline-Based Fluorescent Probe for Quantitative Estimation of Protein Binding Site Polarity,” Chemical Communications, Vol. 47, No. 13, 2011, pp. 3867-3869. doi:10.1039/c1cc10183h</mixed-citation></ref><ref id="scirp.29631-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">N. C. Kakodkar, R. Peddinti, M. Kletzel, Y. Tian, L. J. Guerrero, S. D. Undevia, D. Gear, A. Chlenski, Q. Yang, H. R. Salwen and S. L. Cohn, “The Quinoxaline AntiTumor Agent (R+)XK469 Inhibits Neuroblastoma Tumor Growth,” Pediatric Blood and Cancer, Vol. 56, No. 1, 2011, pp. 164-167. doi:10.1002/pbc.22639</mixed-citation></ref><ref id="scirp.29631-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">A. K. Patidar, M. Jeyakandan, A. K. Moobiya and G. Selvan, “Exploring Potential of Quinoxaline Moiety,” International Journal of PharmTech Research, Vol. 3, No. 1, 2011, pp. 386-392.</mixed-citation></ref><ref id="scirp.29631-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">S. Noorulla and N. Sreenivasulu, “Antibacterial Activity of Novel Substituted Quinoxaline Heterocycles with Isoniazide,” International Journal of Research in Pharmaceutical and Biomedical Sciences, Vol. 2, No. 3, 2011, pp. 1100-1106.</mixed-citation></ref><ref id="scirp.29631-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">S. Khaksar and F. Rostamnezhad, “A Novel One-Pot Synthesis of Quinoxaline Derivatives in Fluorinated Alcohols,” Bulletin of the Korean Chemical Society, Vol. 33, No. 8, 2012, pp. 2581-2584.  
doi:10.5012/bkcs.2012.33.8.2581</mixed-citation></ref><ref id="scirp.29631-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">G. V. Sidorov and N. F. Myasoedov, “Synthesis of Tritium-Labelled Biologically Important Diazines,” Ruissian Chemical Reviews, Vol. 68, No. 3, 1999, pp. 229-240.  
doi:10.1070/RC1999v068n03ABEH000471</mixed-citation></ref><ref id="scirp.29631-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">J. A. Egan, R. P. Nugent and C. N. Filer, “Tritium Labelling and Characterization of the Cognition Enhancing Drug Tacrine Using Several Precursors,” Applied Radiation and Isotopes, Vol. 57, No. 6, 2002, pp. 837-840.  
doi:10.1016/S0969-8043(02)00168-9</mixed-citation></ref><ref id="scirp.29631-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">J. A. Egan and C. N. Filerga, “Tritium Labeling of the Local Anesthetic Tetracaine via a Polyhalogenated Precursor,” Journal of Radioanalytical and Nuclear Chemistry, Vol. 258, No. 1, 2003, pp. 185-187.  
doi:10.1023/A:1026295101076</mixed-citation></ref><ref id="scirp.29631-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">D. G. Ahern, A. G. Laseter and C. N. Filer, “Tritium Labelling of Several Potent Fluorinated Antipsychotic Drugs at High Specific Activity,” Applied Radiation and Isotopes, Vol. 65, No. 7, 2007, pp. 827-830.  
doi:10.1016/j.apradiso.2007.02.008</mixed-citation></ref><ref id="scirp.29631-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">G. Mousseau, Q. Raffy, O. P. Thomas, M. Agez, R. Thai, J. P. Renaul, S. Pin, F. Ochsenbein, J.-C. Cintrat and B. Rousseau, “Footprinting of Protein Interactions by Tritium Labeling,” Biochemistry, Vol. 49, No. 20, 2010, pp. 4297-4299. doi:10.1021/bi100031a</mixed-citation></ref><ref id="scirp.29631-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">G. Heinkele and T. E. Mürdter, “Synthesis of [2H3]Labelled Sulfamethoxazole and Its Main Urinary Metabolites,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 50, No. 7, 2007, pp. 656-659.  
doi:10.1002/jlcr.1375</mixed-citation></ref><ref id="scirp.29631-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">D. Y. W. Lee, X. S. Ji and X. Zhang, “Synthesis of Tritium-Labeled Puerarin—A Potential Antidipsotropic Agent,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 50, No. 8, 2007, pp. 702-705.  
doi:10.1002/jlcr.1398</mixed-citation></ref><ref id="scirp.29631-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">U. Pleiss, “1,4-Dihydropyridines (DHPs)—A Class of Very Potent Drugs: Syntheses of Isotopically Labeled DHP Derivatives during the Last Four Decades,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 50, No. 9-10, 2007, pp. 818-830. doi:10.1002/jlcr.1418</mixed-citation></ref><ref id="scirp.29631-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Y. Hong, S. J. Bonacorsi Jr., Y. Tian, S. Gong, D. Zhang, W. G. Humphreys, B. Balasubramanian, E. H. Cheesman, Z. Zhang, J. F. Castner and P. D. Crane, “Synthesis of [1, 2-3H]Ethylamine Hydrochloride and [3H]-Labeled Apadenoson for a Human ADME Study,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 51, No. 2, 2008, pp. 113-117. doi:10.1002/jlcr.1495</mixed-citation></ref><ref id="scirp.29631-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">W. J. Wheeler and D. K. Clodfelter, “Synthesis of the Tritiated Isotopomers of Enzastaurin and Its N-DesPyridylmethyl Metabolite for Use in ADME Studies,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 51, No. 4, 2008, pp. 175-181.  
doi:10.1002/jlcr.1497</mixed-citation></ref><ref id="scirp.29631-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">S.-Y. Wu and M. R. Masjedizadeh, “Synthesis of Tritium Labelled Thiorphan, an Enkephalinase Inhibitor,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 52, No. 1, 2009, pp. 23-28. doi:10.1002/jlcr.1566</mixed-citation></ref><ref id="scirp.29631-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">C. Zona and B. La Ferla, “Synthesis of Labeled Curcumin Derivatives as Tools for in Vitro Blood Brain Barrier Trafficking Studies,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 54, No. 9, 2011, pp. 629-632.  
doi:10.1002/jlcr.1907</mixed-citation></ref><ref id="scirp.29631-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">J. Malmquist, A. Bernlind, J Sandell, P Strom and M Waldman, “Tritium Labeling of a γ-Secretase Inhibitor and Two Modulators as in Vitro Imaging Agents,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 55, No. 2, 2012, pp. 80-83. doi:10.1002/jlcr.1955</mixed-citation></ref><ref id="scirp.29631-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">W. J. S. Lockley, A. McEwen and R. Cooke, “Tritium: A Coming of Age for Drug Discovery and Development ADME Studies,” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 55, No. 7, 2012, pp. 235-257.  
doi:10.1002/jlcr.2928</mixed-citation></ref><ref id="scirp.29631-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">N. E. Shchepina, V. V. Avrorin, G. A. Badun, G. A. Alexandrova, S. E. Ukhanov, V. M. Fedoseev, S. B. Lewis and I. I. Boiko, “Preparation of N-Phenyl-Substituted Quinolinium Derivatives Labeled with Tritium by Chemonuclear Synthesis,” Chemistry of Heterocyclic Compounds, Vol. 45, No. 7, 2009, pp. 796-801.   
doi:10.1007/s10593-009-0359-7</mixed-citation></ref><ref id="scirp.29631-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">N. E. Shchepina, V. V. Avrorin, G. A. Badun, V. M. Fedoseev and S. B. Lewis, “ New Method for the Synthesis of Difficultly Available Sterically Hindered Tritium-Labeled Pyridinium Derivatives,” Chemistry of Heterocyclic Compounds, Vol. 46, No. 5, 2010, pp. 547-552.  
doi:10.1007/s10593-010-0544-8</mixed-citation></ref><ref id="scirp.29631-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">N. E. Shchepina, V. V. Avrorin, G. A. Badun, S. B. Lewis and S. E. Ukhanov, “Preparation of Fused NPhenyl-Substituted Pyridinium Derivatives by Direct Phenylation with Nucleogenic Phenyl Cations,” Chemistry of Heterocyclic Compounds, Vol. 48, No. 2, 2012, pp. 547-552. doi:10.1007/s10593-012-0990-6</mixed-citation></ref><ref id="scirp.29631-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">N. E. Shchepina, V. V. Avrorin, G. A. Badun, N. A. Bumagin and S. N. Shurov, “Pathways of Ion-Molecular Interactions of Nucleogenic Phenyl Cations with the Nucleophilic Centers of Picolines,” Organic and Medicinal Chemistry Letters, Vol. 2, No. 1, 2012, p. 14.  
doi:10.1186/2191-2858-2-14</mixed-citation></ref><ref id="scirp.29631-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">N. E. Shchepina, V. V. Avrorin, G. A. Badun, S. B. Lewis and S. N. Shurov, “New Way of Direct Nitrogen Atom Phenylation in Quinoline Derivatives,” ISRN Organic Chemistry, Vol. 2012, 2012, Article ID: 526867, pp. 1-4.</mixed-citation></ref><ref id="scirp.29631-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">N. E. Shchepina, V. V. Avrorin, G. A. Badun, S. B. Lewis, V. M. Fedoseev and S. E. Ukhanov, “ The Reaction of Direct Phenylation by Nucleogenic Cations as a Method of Synthesis of Unknown or Complicated Tritium Labeled Compounds,” Moscow University Chemistry Bulletin, Vol. 64, No. 5, 2009, pp. 244-248.  
doi:10.3103/S0027131409050034</mixed-citation></ref><ref id="scirp.29631-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">G. F. Duffin, “The Quaternization of Heterocyclic Compounds,” Advances in Heterocyclic Chemistry, Vol. 3, 1964, pp. 1-56. doi:10.1016/S0065-2725(08)60540-1</mixed-citation></ref><ref id="scirp.29631-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">B. Pilarski and K. OsMialowski, “The Relationship between Electron Densities and the pKa Values in a Series of Methylpyrazines,” International Journal of Quantum Chemistry, Vol. 28, No. 2, 1985, pp. 239-244.  
doi:10.1002/qua.560280207</mixed-citation></ref><ref id="scirp.29631-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">T. J. Curphey and K. S. Prasad, “Diquaternary Salts. I. Preparation and Characterization of the Diquaternary Salts of Some Diazines and Diazoles,” The Journal of Organic Chemistry, Vol. 37, No. 14. 1972. pp. 2259-2266.  
doi:10.1021/jo00979a012</mixed-citation></ref></ref-list></back></article>